Background A considerable proportion of individuals report persistent, debilitating and
disparate symptoms despite resolution of acute COVID-19 infection (ie long COVID) …

Introduction Over three years have passed since the emergence of coronavirus disease
2019 (COVID-19), and yet the treatment for long-COVID, a post-COVID-19 syndrome …

The postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
infection (PASC), also known as post‐acute coronavirus disease 19 (COVID‐19) or the long …

Introduction Long-COVID is a condition characterized by the permanence of symptoms
beyond 4 weeks after an initial infection. It affects 1 out of 5 people and is loosely related to …

Long-lasting coronavirus disease 2019 (COVID-19) symptoms beyond 12 weeks, the so-
called 'long COVID'have been increasingly reported worldwide. Long COVID can be …

Scope The aim of these guidelines is to provide evidence-based recommendations for the
assessment and management of individuals with persistent symptoms after acute COVID-19 …

Postacute sequelae of COVID-19, or long COVID, has affected millions of people, with a
broad range of symptoms such as fatigue, postexertional malaise, and cognitive dysfunction …

Background The aim of this study was to systematically synthesise the global evidence on
the prevalence of persistent symptoms in a general post COVID-19 population. Methods A …

Although most individuals recover from acute SARS-CoV-2 infection, a significant number
continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the …

Objectives The coronavirus disease 2019 (COVID-19) pandemic has prompted many
initiatives to identify safe and efficacious treatments, yet little is known regarding where early …